| (Values in U.S. Thousands) | Mar, 2018 | Dec, 2017 | Sep, 2017 | Jun, 2017 | Mar, 2017 |
| Sales | -9,999,000 | 140,360 | 73,350 | 72,090 | 0 |
| Sales Growth | -7,223.82% | +91.36% | +1.75% | unch | unch |
| Net Income | -9,999,000 | 3,960 | 2,750 | 4,900 | -1,230 |
| Net Income Growth | -252,599.94% | +44.00% | -43.88% | +498.37% | +52.51% |
Standard Diversified Opportunities Inc (SDOIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Standard Diversified Opportunities Inc. provides biotechnology-based diagnostic tests for a broad range of commercial applications. Standard Diversified Opportunities Inc., formerly known as Special Diversified Opportunities Inc., is headquartered in Wilmington, Delaware.